Prashanth Ashok Kumar

20PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 08, 2025
The impact of adjuvant chemotherapy on overall survival in premenopausal (age ≤ 50 years) hormone and node positive breast cancer patients with an Oncotype Dx score of 25 or less. A NCDB analysis.

Prashanth Ashok Kumar, Ghanshyam Ghelani, Gowthami Koorapati

|Dec 08, 2025
Cardiac Involvement in Systemic Lupus Erythematosus.

Vrinda Vyas, Vandita Vyas, Akash Sharma

|Jul 09, 2025
Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines.

Vrinda Vyas, Vandita Vyas, Akash Sharma

|Jan 18, 2025
A meta-analysis of the utility of cryotherapy for preventing peripheral neuropathy among breast cancer patients receiving paclitaxel and nab-paclitaxel.

Prashanth Ashok Kumar, Parth Sampat, Michael Sandhu

|Dec 20, 2024
Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images.

Sushant Patkar, Alex Chen, Alina Basnet

|Apr 02, 2024
Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database.

Prashanth Ashok Kumar, Dongliang Wang, Danning Huang

Pageof 4

Frequent Collaborators

2 joint publications

Tamara Jamaspishvili

2 joint publications

Vrinda Vyas

2 joint publications

Stephanie Harmon

2 joint publications

Akash Sharma